Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Akari Therapeutics plc, 1 year.
Akari Therapeutics plc
Director · CEO
Chief executive roles
Akari Therapeutics plc
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Akari Therapeutics plc | Open-market purchase | +3,000 | $0.90 | $2,700 |
| Aug 22, 2025 | Akari Therapeutics plc | Open-market purchase | +8,000 | $0.93 | $7,440 |
| Aug 21, 2025 | Akari Therapeutics plc | Open-market purchase | +10,000 | $0.94 | $9,400 |
| Jun 24, 2025 | Akari Therapeutics plc | Open-market purchase | +5,203 | $1.16 | $6,035 |
| Jun 23, 2025 | Akari Therapeutics plc | Open-market purchase | +943 | $1.15 | $1,084 |
| Jun 20, 2025 | Akari Therapeutics plc | Open-market purchase | +10,000 | $1.20 | $12,000 |
| Jun 17, 2025 | Akari Therapeutics plc | Open-market purchase | +15,000 | $1.20 | $18,000 |
| Jun 13, 2025 | Akari Therapeutics plc | Grant or award | +25,000 | $1.19 | $29,750 |
| Jun 12, 2025 | Akari Therapeutics plc | Grant or award | +20,000 | $1.23 | $24,600 |
| Jun 10, 2025 | Akari Therapeutics plc | Grant or award | +20,000 | $1.27 | $25,400 |
| Mar 6, 2025 | Akari Therapeutics plc | Grant or award | +133,928 | $1.12 | $149,999 |
| Jan 10, 2025 | Akari Therapeutics plc | Grant or award | +11,439 | $1.22 | $13,956 |
| Jan 3, 2025 | Akari Therapeutics plc | Grant or award | +1,720,000 | — | — |
| Dec 27, 2024 | Akari Therapeutics plc | Grant or award | +40,000,000 | — | — |
| Dec 26, 2024 | Akari Therapeutics plc | Grant or award | +30,000,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.